Neoadjuvant and Adjuvant Therapy in Intrahepatic Cholangiocarcinoma

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer and causes major economic and health burdens throughout the world. Although the incidence of ICC is relatively low, an upward trend has been seen over the past few decades. Owing to the lack of specific manifestatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xing, Du, Jinpeng, Huang, Jiwei, Zeng, Yong, Yuan, Kefei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240234/
https://www.ncbi.nlm.nih.gov/pubmed/35836758
http://dx.doi.org/10.14218/JCTH.2021.00250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240234/
https://www.ncbi.nlm.nih.gov/pubmed/35836758
http://dx.doi.org/10.14218/JCTH.2021.00250

Ejemplares similares